EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Abnormal Antithyroglobulin Antibody in a Woman With Papillary Thyroid Carcinoma Receiving Intravenous Immunoglobulin Treatment

Verdah Ahmad, Sara Lubitz

AACE Clinical Case Reports · 2025-03 · 11 (2) · 131-133

DOI: 10.1016/j.aace.2024.12.010 ↗

Kurz gefasst

Fallbericht in der Zeitschrift AACE Clinical Case Reports, 2025-03. Verfasst von Verdah Ahmad und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Metabolism and Nutrition, Department of Medicine, Robert Wood Johnson Medical School, New Brunswick, New Jersey. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Thyroglobulin and antithyroglobulin antibodies are used in the surveillance of differentiated thyroid carcinomas. In patients with differentiated thyroid carcinoma who require intravenous immunoglobulin for autoimmune or malignant conditions, surveillance of antithyroglobulin antibodies is challenging. We present a case of a patient with papillary thyroid carcinoma who showed fluctuating antithyroglobulin antibody levels while receiving intravenous immunoglobulin. Case Presentation: A 41-year-old woman underwent total thyroidectomy, central and left modified neck dissection, and radioactive iodine ablation for multifocal papillary thyroid carcinoma with features of oncocytic and warthin-like variant and metastasis to 1 of 28 left lateral and 1 of 10 central lymph nodes. Ten years later, she contracted COVID-19 and developed COVID-19-associated encephalopathy for which she received intravenous immunoglobulin for 7 months. Five months after intravenous immunoglobulin initiation, surveillance thyroglobulin was

Schlagwörter

Stichwörter der Autor:innen

antithyroglobulin antibodydifferentiated thyroid carcinomaintravenous immunoglobulinthyroglobulin

Autor:innen und Institutionen

  • Division of Endocrinology, Metabolism and Nutrition, Department of Medicine, Robert Wood Johnson Medical School, New Brunswick, New Jersey.

Zitieren

APA

Ahmad, V., & Lubitz, S. (2025). Abnormal Antithyroglobulin Antibody in a Woman With Papillary Thyroid Carcinoma Receiving Intravenous Immunoglobulin Treatment. AACE Clinical Case Reports, 11(2), 131-133. https://doi.org/10.1016/j.aace.2024.12.010

Vancouver

Ahmad V, Lubitz S. Abnormal Antithyroglobulin Antibody in a Woman With Papillary Thyroid Carcinoma Receiving Intravenous Immunoglobulin Treatment. AACE Clinical Case Reports. 2025;11(2):131-133. doi:10.1016/j.aace.2024.12.010

BibTeX
@article{Ahmad2025,
  author = {Ahmad, Verdah and Lubitz, Sara},
  title = {Abnormal Antithyroglobulin Antibody in a Woman With Papillary Thyroid Carcinoma Receiving Intravenous Immunoglobulin Treatment},
  journal = {AACE Clinical Case Reports},
  year = {2025},
  volume = {11},
  number = {2},
  pages = {131--133},
  doi = {10.1016/j.aace.2024.12.010}
}
Kostenlos starten →